Spred1 deficit promotes treatment resistance and transformation of chronic phase CML von Qiao, Junjing, Liang, Chen, Zhao, Dandan, Nguyen, Le Xuan Truong, Chen, Fang, Suo, Shanshan, Hoang, Dinh Hoa, Pellicano, Francesca, Rodriguez, Ivan Rodriguez, Elhajmoussa, Yasmin, Ghoda, Lucy, Yoshimura, Akihiko, Stein, Anthony S., Ali, Haris, Koller, Paul, Perrotti, Danilo, Copland, Mhairi, Han, Anjia, Zhang, Bin (Amber), Marcucci, Guido

Volltext

Ropeginterferon alfa-2b shows anti-polycythaemia vera activity without causing clinically significant anaemia von Kirito, Keita, Qin, Albert, Suo, Shanshan, Fu, Rongfeng, Wu, Daoxiang, Sato, Toshiaki, Zagrijtschuk, Oleh, Shimoda, Kazuya, Komatsu, Norio, Jin, Jie

Volltext

Evaluation of gecacitinib vs hydroxyurea in patients with intermediate-2 or high-risk myelofibrosis: final analysis results from a randomized phase 3 study von Zhang, Yi, Zhou, Hu, Suo, Shanshan, Zhuang, Junling, Yang, Linhua, He, Aili, Liu, Qingchi, Du, Xin, Gao, Sujun, Li, Yarong, Li, Yan, Chen, Yuqing, Wu, Wen, Zhu, Huanling, He, Guangsheng, Hong, Mei, Jiang, Qian, Jiang, Zhongxing, Jing, Hongmei, Wang, Jishi, Xu, Na, Yue, Lingling, Zheng, Cuiping, Zhou, Zeping, Jin, Chenghao, Li, Xin, Liu, Lin, Xu, Yajing, Wu, Dengshu, Zhang, Feng, Zhang, Jin, Wu, Liqing, Yin, Hewen, Lv, Binhua, Xiao, Zhijian, Jin, Jie

Volltext

P1033: JAKTINIB IN PATIENTS WITH MYELOFIBROSIS WHO WERE REFRACTORY OR RELAPSED TO RUXOLITINIB: A SINGLE‐ARM, OPEN‐LABEL, MULTICENTER, PHASE 2 STUDY von Zhang, Yi, Zhang, Qike, Liu, Qingchi, Dang, Huibing, Gao, Sujun, Wang, Wei, Zhou, Hu, Chen, Yuqing, MA, Liangming, Wang, Jishi, Zhao, Peng, Yang, Haiping, Zhao, Qingwei, Suo, Shanshan, Jin, Jie

Volltext

miR-221-3p Delivered by BMMSC-Derived Microvesicles Promotes the Development of Acute Myelocytic Leukemia von Zhang, Xuewu, Xu, Yu, Wang, Jinghan, Zhao, Shuqi, Li, Jianhu, Huang, Xin, Xu, Huan, Zhang, Xiang, Suo, Shanshan, Lv, Yunfei, Zhang, Yi, Yu, Wenjuan

Volltext

Sodium chloride improves seed vigour of the euhalophyte Suaeda salsa von Guo, Jianrong, Suo, Shanshan, Wang, Bao-Shan

Volltext

IDH1R132S‐mutated acute lymphoblastic leukaemia resembles Burkitt lymphoma/leukaemia via activating MYC von Zhang, Xiang, Suo, Shanshan, Wang, Jinghan, Jin, Jie, Yu, Wenjuan

Volltext

I DH1 R132S ‐mutated acute lymphoblastic leukaemia resembles Burkitt lymphoma/leukaemia via activating MYC von Zhang, Xiang, Suo, Shanshan, Wang, Jinghan, Jin, Jie, Yu, Wenjuan

Volltext

Identification and functional analysis of the autofluorescent substance in Limonium bicolor salt glands von Deng, Yunquan, Feng, Zhongtao, Yuan, Fang, Guo, Jianrong, Suo, Shanshan, Wang, Baoshan

Volltext

MN1::ETV6‐positive de novo T‐cell acute lymphoblastic leukaemia is sensitive to venetoclax: A case report von Zhang, Xiang, Zhong, Yi, Liu, Lixia, Suo, Shanshan, Zhao, Shuqi, Xiao, Feng, Qin, Jiayue, Tong, Hongyan, Jin, Jie, Yu, Wenjuan

Volltext

Combination of Olverembatinib and VP Regimen As First-Line Therapy for Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia von Xu, Gaixiang, Lou, Yinjun, Wang, Huafeng, Yu, Wen-Juan, Mao, Liping, Huang, Jian, Li, Chenying, Suo, Shanshan, Tong, Hongyan, Jin, Jie

Volltext

Venetoclax Combined with Hag Regimen in Newly Diagnosed ETP-ALL: Interim Analysis of a Prospective, Multicenter, Phase 2 Trial von Suo, Shanshan, Yu, Wen-Juan, Lu, Ying, Qian, Jiejing, Mao, Liping, Wang, Jin, Shen, Lijing, Li, Bingzong, Wang, Huafeng, MAI, Wenyuan, Xie, Wanzhuo, Wang, Xiaomin, Zhao, Dan, Liu, Yuanfang, He, Chuan, Jin, Jie

Volltext

Jaktinib in patients (pts) with myelofibrosis (MF) who were refractory to or relapsed after ruxolitinib: A single-arm, open-label, multicenter, phase 2 study von Jin, Jie, Zhang, Yi, Zhang, Qike, Liu, Qingchi, Zhou, Hu, Gao, Sujun, Wang, Wei, Dang, Huibing, Chen, Yuqing, Wang, Jishi, Zhao, Peng, Yang, Haiping, Ma, Liangming, Zhao, Qingwei, Suo, Shanshan

Volltext

Molecular remission uncoupled with complete haematological response in polycythaemia vera treatment with ropeginterferon alfa‐2b von Suo, Shanshan, Fu, Rong Feng, Qin, Albert, Shao, Zonghong, Bai, Jie, Zhou, Hu, Xu, Na, Chen, Suning, Zuo, Xuelan, Du, Xin, Duan, Minghui, Wang, Li, Li, Pei, Zhang, Xuhan, Zhang, Sujiang, Wu, Daoxiang, Zhang, Jingjing, Xiao, Zhijian, Zhang, Lei, Jin, Jie

Volltext

Osteolytic lesion as initial presentation in FIP1L1-PDGFRA-rearranged myeloid/lymphoid neoplasm with eosinophilia: a case report von Lv, Yunfei, Yao, XingYun, Ling, Qing, Suo, Shanshan, Wang, Jinghan, Zhao, Shuqi, Gao, Xiaofei, Tong, Hongyan, Jin, Jie, Zhang, Xiang, Yu, Wenjuan

Volltext

Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are relapsed or refractory to ruxolitinib: A single-arm, open-label, phase 2, multicenter... von Zhang, Yi, Zhang, Qike, Liu, Qingchi, Dang, Huibing, Gao, Sujun, Wang, Wei, Zhou, Hu, Chen, Yuqing, Ma, Liangming, Wang, Jishi, Yang, Haiping, Lu, Binhua, Yin, Hewen, Wu, Liqing, Suo, Shanshan, Zhao, Qingwei, Tong, Hongyan, Jin, Jie

Volltext

Homoharringtonine Exhibits Anti-Tumor Effect in T-Cell Acute Lymphoblastic Leukemia By Targeting Notch1/Myc Pathway von Suo, Shanshan, Zhao, Dandan, Li, Fenglin, Rodriguez, Sonia, Qiao, Junjing, Liang, Chen, Nguyen, Le Xuan Truong, Hoang, Dinh Hoa, Chen, Fang, Rodriguez, Ivan, Ghoda, Lucy, McDonald, Tinisha, Li, Ling, Carlesso, Nadia, Zhang, Bin, Marcucci, Guido, Jin, Jie

Volltext

Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are intolerant to ruxolitinib: A single-arm, open-label, phase 2, multicenter study von Zhang, Yi, Zhou, Hu, Duan, Minghui, Gao, Sujun, He, Guangsheng, Jing, Hongmei, Li, Junmin, Ma, Liangming, Zhu, Huanling, Chang, Chunkang, Du, Xin, Hong, Mei, Li, Xin, Liu, Qingchi, Wang, Wei, Xu, Na, Yang, Haiping, Lu, Binhua, Yin, Hewen, Wu, Liqing, Suo, Shanshan, Zhao, Qingwei, Xiao, Zhijian, Jin, Jie

Volltext

Efficacy, Safety, and Survival Findings after Long-Term Follow-up from ZGJAK002, a Phase 2 Study Comparing Jaktinib 100 Mg Twice Daily with 200 Mg Once Daily for Myelofibrosis (MF) von Zhang, Yi, Zhou, Hu, Jiang, Zhongxing, Wu, Dengshu, Zhuang, Junling, Li, Wei, Jiang, Qian, Wang, Xiuli, Huang, Jinwen, Zhu, Huanling, Yang, Linhua, Du, Xin, Li, Fei, Xia, Ruixiang, Zhang, Feng, Hu, Jianda, Li, Yan, Hu, Yu, Liu, Jing, Jin, Chenghao, Sun, Kai, Zhou, Zeping, Suo, Shanshan, Yu, Wenjuan, Jin, Jie

Volltext

Acute Myeloid Leukemia Cell-Intrinsic PD-1 Functions Promoting Leukemia Development By Recruiting SHP2 von Suo, Shanshan, Nguyen, Le Xuan Truong, Li, Fenglin, Zhao, Dandan, Qiao, Junjing, Liang, Chen, Hoang, Dinh Hoa, Chen, Fang, Rodriguez, Ivan, Ghoda, Lucy, McDonald, Tinisha, Li, Ling, Zhang, Bin Amber, Jin, Jie, Marcucci, Guido

Volltext